Free Cash Flow CAGR:9.05%(TTM)
Free cash flow CAGR uses precomputed cash-flow statement history.
Over longer horizons, Free Cash Flow CAGR averages -16.09% over 3 years and 92.70% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Free cash flow CAGR measures how the company's cash generation has grown. FCF represents the cash available for dividends, buybacks, debt reduction, or reinvestment.
ALB Free Cash Flow CAGR Chart
Albemarle Corporation (ALB)
ALB Quarterly Free Cash Flow Growth (YoY)
Free Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
ALB Free Cash Flow CAGR History
| Year | Start FCF | End FCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $-992.65M | $692.47M | +$1.69B | N/A | N/A |
| 2024 | $-827.96M | $-992.65M | $-164.69M | N/A | N/A |
| 2023 | $646.20M | $-827.96M | $-1.47B | -228.13% | N/A |
| 2022 | $-609.41M | $646.20M | +$1.26B | N/A | N/A |
| 2021 | $-51.56M | $-609.41M | $-557.85M | N/A | N/A |
| 2020 | $-132.42M | $-51.56M | +$80.86M | N/A | N/A |
| 2019 | $-153.83M | $-132.42M | +$21.40M | N/A | N/A |
| 2018 | $-13.72M | $-153.83M | $-140.10M | N/A | N/A |
| 2017 | $536.75M | $-13.72M | $-550.47M | -102.56% | N/A |
| 2016 | $133.04M | $536.75M | +$403.71M | +303.45% | +303.45% |
| 2015 | $382.03M | $133.04M | $-248.99M | -65.18% | -65.18% |
| 2014 | $277.51M | $382.03M | +$104.52M | +37.66% | +37.66% |
| 2013 | $207.89M | $277.51M | +$69.62M | +33.49% | +33.49% |
| 2012 | $259.84M | $207.89M | $-51.95M | -19.99% | -19.99% |
| 2011 | $255.83M | $259.84M | +$4.01M | +1.57% | +1.57% |
| 2010 | $257.74M | $255.83M | $-1.91M | -0.74% | -0.74% |
| 2009 | $216.01M | $257.74M | +$41.73M | +19.32% | +19.32% |
| 2008 | $143.80M | $216.01M | +$72.21M | +50.21% | +50.21% |
| 2007 | $276.45M | $143.80M | $-132.65M | -47.98% | -47.98% |
| 2006 | $98.78M | $276.45M | +$177.66M | +179.86% | +179.86% |
| 2005 | $133.90M | $98.78M | $-35.12M | -26.23% | -26.23% |
| 2004 | $109.04M | $133.90M | +$24.86M | +22.80% | +22.80% |
| 2003 | $106.39M | $109.04M | +$2.65M | +2.49% | +2.49% |
| 2002 | $94.06M | $106.39M | +$12.33M | +13.11% | +13.11% |
| 2001 | $102.82M | $94.06M | $-8.76M | -8.52% | -8.52% |
| 2000 | $86.73M | $102.82M | +$16.09M | +18.55% | +18.55% |
| 1999 | $60.47M | $86.73M | +$26.26M | +43.43% | +43.43% |
| 1998 | $13.52M | $60.47M | +$46.94M | +347.11% | +347.11% |
| 1997 | $-61.97M | $13.52M | +$75.49M | N/A | N/A |
Quarterly Free Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $247.57M | +6.2% | -31.8% |
| Q4 2025 | $233.10M | +4.3% | — |
| Q3 2025 | $223.44M | — | — |
| Q2 2025 | -$126.83M | — | -44.0% |
| Q1 2025 | $362.76M | — | — |
| Q4 2024 | -$355.05M | -367.1% | +54.6% |
| Q3 2024 | -$76.02M | +13.7% | — |
| Q2 2024 | -$88.08M | +81.7% | +79.5% |
| Q1 2024 | -$481.37M | +38.5% | — |
| Q4 2023 | -$782.31M | — | — |
| Q3 2023 | $82.95M | — | -85.7% |
| Q2 2023 | -$429.98M | — | -3.2% |
| Q1 2023 | $305.37M | -39.7% | — |
| Q4 2022 | $506.54M | -13.0% | — |
| Q3 2022 | $581.96M | — | — |
| Q2 2022 | -$416.77M | -1533.0% | — |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Albemarle Corporation
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Jerry Kent Jr.